November 7, 2019
The Innovator Awards recognize Association of Community Cancer Center member programs for their ingenuity and pioneering achievements in oncology. Innovations advance the goals of improving access, quality, and value in cancer care delivery.
October 9, 2019
Emily Harrison, PhD, a postdoc at the UNC Lineberger Comprehensive Cancer Center, was awarded $150,000 for research focused on inhibiting the mechanisms of lung cancer metastasis.
June 27, 2019
Kate Westmoreland, MD, has been amazed and excited by a surge of support for her work to improve treatment for adolescents and young adults with Burkitt lymphoma in Malawi, a country in Sub-Saharan Africa where this type of blood cancer is more common and deadly than in the United States.
April 18, 2019
Four UNC Lineberger researchers – Leaf Huang, Alexander Kabanov, Andrew Wang, and Jenny Ting – presented strategies for using tiny particles to boost cancer treatment as part of a National Cancer Institute site visit.
January 3, 2019
UNC Lineberger’s Joshua Zeidner, MD, reported preliminary data at the 60th American Society of Hematology Annual Meeting from a phase II clinical trial for administering a high-dose of the chemotherapy treatment cytarabine followed by an immune checkpoint inhibitor, pembrolizumab, in patients with acute myeloid leukemia that had relapsed or no longer responded to other treatment.
December 18, 2018
UNC scientists led by Brian Strahl, PhD, and Raghuvar Dronamraju, PhD, uncovered a key regulatory step in gene expression that may be a significant factor in cancers and other major diseases.
November 15, 2018
The National Cancer Institute’s Outstanding Investigator Award supports accomplished leaders in cancer research.
August 2, 2018
Sebastian Gonzalez and his family traveled from Costa Rica to North Carolina for one reason: to be treated by Andrea Hayes-Jordan, MD. Hayes-Jordan serves as Chief of the Division of Pediatric Surgery at the UNC School of Medicine, and Surgeon in Chief at the North Carolina Children’s Hospital. She's also one of the few physicians in the world to specialize in the treatment of Desmoplastic small round cell tumor, Sebastian’s rare form of cancer.
June 4, 2018
A study by UNC Lineberger's Ronald Chen, MD, MPH, and colleagues assessed whether monitoring prostate cancer patients following treatment with a PSA test every three months versus once a year would provide a long-term survival benefit.
May 29, 2018
UNC Lineberger researchers led by Blossom Damania, PhD, and Penny Anders, PhD, published a paper in the Journal of Clinical Investigation that explains how the viral protein vPK helps drive abnormal growth of immune cells called B cells. Their findings identify vPK as a potential druggable target to block or treat cancer in people infected with the virus.
April 12, 2018
As a member of Susan G. Komen’s Scientific Advisory Board, UNC Lineberger’s Lisa A. Carey, MD, will be responsible for helping guide Komen’s $956-million research program – second only to the U.S. government in funding of breast cancer research.
April 12, 2018
Compared to physicians who didn’t receive any payments, those who received payments for meals and lodging from a drug manufacturer had higher odds of prescribing that company’s particular drug for certain cancers, reported Aaron Mitchell, MD, and colleagues in JAMA Internal Medicine.